These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31000085)

  • 21. Risk of developing radiogenic cancer following photon-beam radiotherapy for Graves' orbitopathy.
    Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
    Med Phys; 2018 Oct; 45(10):4775-4782. PubMed ID: 30105825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiobiologic comparison of helical tomotherapy, intensity modulated radiotherapy, and conformal radiotherapy in treating lung cancer accounting for secondary malignancy risks.
    Komisopoulos G; Mavroidis P; Rodriguez S; Stathakis S; Papanikolaou N; Nikiforidis GC; Sakellaropoulos GC
    Med Dosim; 2014; 39(4):337-47. PubMed ID: 25168596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac dose-sparing effects of deep-inspiration breath-hold in left breast irradiation : Is IMRT more beneficial than VMAT?
    Sakka M; Kunzelmann L; Metzger M; Grabenbauer GG
    Strahlenther Onkol; 2017 Oct; 193(10):800-811. PubMed ID: 28646251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SECOND CANCER RISK FROM RADIATION THERAPY FOR COMMON SOLID TUMORS DIAGNOSED IN REPRODUCTIVE-AGED FEMALES.
    Mazonakis M; Kachris S; Damilakis J
    Radiat Prot Dosimetry; 2018 Dec; 182(2):208-214. PubMed ID: 29608744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second cancer risk assessments after involved-site radiotherapy for mediastinal Hodgkin lymphoma.
    Mazonakis M; Lyraraki E; Damilakis J
    Med Phys; 2017 Jul; 44(7):3866-3874. PubMed ID: 28493609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk evaluation of secondary malignancies after radiotherapy of breast cancer in light of the continuous development of planning techniques.
    Cilla S; Deodato F; Romano C; Macchia G; Buwenge M; Boccardi M; Pezzulla D; Pierro A; Zamagni A; Morganti AG
    Med Dosim; 2023 Winter; 48(4):279-285. PubMed ID: 37659968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Propensity-score-matched evaluation of the incidence of radiation pneumonitis and secondary cancer risk for breast cancer patients treated with IMRT/VMAT.
    Chao PJ; Lee HF; Lan JH; Guo SS; Ting HM; Huang YJ; Chen HC; Lee TF
    Sci Rep; 2017 Oct; 7(1):13771. PubMed ID: 29062118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting the risk of secondary lung malignancies associated with whole-breast radiation therapy.
    Ng J; Shuryak I; Xu Y; Clifford Chao KS; Brenner DJ; Burri RJ
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1101-6. PubMed ID: 22245205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiation dose and cancer risk to out-of-field and partially in-field organs from radiotherapy for symptomatic vertebral hemangiomas.
    Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
    Med Phys; 2016 Apr; 43(4):1841. PubMed ID: 27036581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy.
    Murray LJ; Thompson CM; Lilley J; Cosgrove V; Franks K; Sebag-Montefiore D; Henry AM
    Phys Med Biol; 2015 Feb; 60(3):1237-57. PubMed ID: 25590229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The risk for developing a secondary cancer after breast radiation therapy: Comparison of photon and proton techniques.
    Paganetti H; Depauw N; Johnson A; Forman RB; Lau J; Jimenez R
    Radiother Oncol; 2020 Aug; 149():212-218. PubMed ID: 32464163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The risk of secondary cancer in nasopharyngeal carcinoma paediatric patients due to intensity modulated radiotherapy and mega-voltage cone beam computed tomography.
    Sherif RS; Attalla EM; Elshemey WM; Madian NG
    J Med Imaging Radiat Oncol; 2017 Jun; 61(3):402-409. PubMed ID: 28019086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A critical evaluation of secondary cancer risk models applied to Monte Carlo dose distributions of 2-dimensional, 3-dimensional conformal and hybrid intensity-modulated radiation therapy for breast cancer.
    Joosten A; Bochud F; Moeckli R
    Phys Med Biol; 2014 Aug; 59(16):4697-722. PubMed ID: 25082795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimation of radiation-induced secondary cancer risks for early-stage non-small cell lung cancer patients after stereotactic body radiation therapy.
    Han C; Schultheiss TE; Wong JYC
    Pract Radiat Oncol; 2017; 7(3):e185-e194. PubMed ID: 28089479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicted risk of radiation-induced cancers after involved field and involved node radiotherapy with or without intensity modulation for early-stage hodgkin lymphoma in female patients.
    Weber DC; Johanson S; Peguret N; Cozzi L; Olsen DR
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):490-7. PubMed ID: 20800383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06.
    Deutsch M; Land SR; Begovic M; Wieand HS; Wolmark N; Fisher B
    Cancer; 2003 Oct; 98(7):1362-8. PubMed ID: 14508821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multileaf field-in-field forward-planned intensity-modulated dose compensation for whole-breast irradiation is associated with reduced contralateral breast dose: a phantom model comparison.
    Borghero YO; Salehpour M; McNeese MD; Stovall M; Smith SA; Johnson J; Perkins GH; Strom EA; Oh JL; Kirsner SM; Woodward WA; Yu TK; Buchholz TA
    Radiother Oncol; 2007 Mar; 82(3):324-8. PubMed ID: 17157944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of IMRT and proton radiotherapy on secondary cancer incidence.
    Schneider U; Lomax A; Pemler P; Besserer J; Ross D; Lombriser N; Kaser-Hotz B
    Strahlenther Onkol; 2006 Nov; 182(11):647-52. PubMed ID: 17072522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Planning aspects of volumetric modulated arc therapy and intensity modulated radio therapy in carcinoma left breast--a comparative study.
    Ekambaram V; Velayudham R; Swaminathan S; Loganathan P; Swaminathan V
    Asian Pac J Cancer Prev; 2015; 16(4):1633-6. PubMed ID: 25743844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Automated planning of tangential breast intensity-modulated radiotherapy using heuristic optimization.
    Purdie TG; Dinniwell RE; Letourneau D; Hill C; Sharpe MB
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):575-83. PubMed ID: 21237584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.